FELDMANN CYNTHIA L
Known title: DirectorCIK: 0001264554
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 5, 2026
ARE Finalizes $5 Billion Credit Facility Refinancing. Alexandria Real Estate Equities has closed its amended $5 billion unsecured senior line of credit. This move comes as the stock faces broader pressure from rising interest rates, with the share price currently near key support levels. The refinancing provides the company with updated liquidity options in a challenging rate environment.
Transaction History
| STE | ▼ Sell | Open Market | 3,098 | $735K | 3/5/2026 | View on chart |
| STE | ▲ Buy | Option Exercise | 3,098 | $472K | 3/5/2026 | View on chart |
| STE | ▲ Buy | Option Exercise | 3,495 | $0 | 8/11/2025 | View on chart |
| STE | ▼ Sell | Open Market | 3,495 | $844K | 8/11/2025 | View on chart |
| ARE | ▲ Buy | Grant | 2,032 | $0 | 1/15/2025 | View on chart |
| STE | ▲ Buy | Option Exercise | 2,000 | $172K | 5/15/2024 | View on chart |
| STE | ▼ Sell | Open Market | 2,000 | $475K | 5/15/2024 | View on chart |
| ARE | ▲ Buy | Grant | 1,585 | $0 | 1/12/2024 | View on chart |
| STE | ▼ Sell | Open Market | 1,127 | $235K | 5/16/2023 | View on chart |
| STE | ▲ Buy | Option Exercise | 2,058 | $177K | 5/16/2023 | View on chart |
| STE | ▼ Sell | Open Market | 931 | $195K | 5/16/2023 | View on chart |
| ARE | ▲ Buy | Grant | 1,125 | $0 | 1/13/2023 | View on chart |
| ARE | ▲ Buy | Grant | 1,000 | $0 | 3/24/2022 | View on chart |
| STE | ▲ Buy | Option Exercise | 1,891 | $135K | 2/10/2022 | View on chart |
| STE | ▼ Sell | Open Market | 1,891 | $443K | 2/10/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
STERIS (STE) to acquire Xodus Medical for $2.1B
STERIS announced a definitive agreement to acquire Xodus Medical for about $2.1 billion. The deal adds a specialty surgical products business focused on patient and operating‑room staff safety, expanding STE’s consumables portfolio. The acquisition aligns with the company’s strategy to grow its healthcare offerings.
STERIS (STE) to acquire Xodus Medical for $2.1B. STERIS announced a definitive agreement to acquire Xodus Medical for about $2.1 billion. The deal adds a specialty surgical products business focused on patient and operating‑room staff safety, expanding STE’s consumables portfolio. The acquisition aligns with the company’s strategy to grow its healthcare offerings.